Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Microbiology|August 1, 1997
Phylogenetic placement and characterization of a new alpha-2 proteobacterium isolated from a patient with sepsisG Blomqvist, L Wesslén, C Påhlson, et al.
Vaccine|November 19, 1997
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogenD Davis, B Morein, L Akerblom, et al.
Journal of Medical Primatology|February 1, 1992
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccinesJ L Heeney, P de Vries, R Dubbes, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphologyR W Humphrey, A Ohagen, D A Davis, et al.
Clinical and Experimental Immunology|March 11, 2004
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOMA M González, T V Nguyen, M S P Azevedo, et al.
Virology|February 3, 1997
The morphology of the immature HIV-1 virionA Ohagen, R B Luftig, A S Reicin, et al.
Journal of Medical Primatology|September 25, 1998
The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protectionJ L Heeney, M E van Gils, P van der Meide, et al.
Vaccine|October 1, 1989
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)S W Pyle, B Morein, J W Bess, et al.
Journal of Medical Primatology|December 11, 1999
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virusE J Verschoor, D Davis, M van Gils, et al.
Vaccine|August 19, 2003
Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigsT V Nguyen, C Iosef, K Jeong, et al.
Pageof 19